MICC Injectable MICC combines methionine, inositol, choline, and cyanocobalamin (vitamin B12) into an injectable designed to support metabolism and energy
Studies have documented its capacity to stimulate collagen and glycosaminoglycan synthesis, accelerate wound healing, promote angiogenesis, exert antioxidant and anti-inflammatory effects, and modulate the expression of genes involved in tissue repair and regeneration
Exceptional safety margin No dependence or tolerance naturally occurring endogenous peptide Tolerability in clinical trials No tolerance develops with repeated doses No withdrawal symptoms upon stopping Peptide naturally present in the human body Research considerations Researcher's notes Outstanding safety profile for a bioactive peptide No serious adverse events were reported in the published studies
(Osaka, Japan), Pfizer Japan Inc
For a comprehensive review of these mechanisms, a peer-reviewed study in Cell and Tissue Research documenting the role of gastric pentadecapeptide BPC-157 in accelerating musculoskeletal soft tissue healing lays out the signaling cascade in detail
It is not intended for human consumption or diagnostic use